CALR and COVID-19: A study in China reported prevalence of 20% anti-52 kDa SSA/Ro antibody, 25% anti-60 kDa SSA/Ro antibody, and 50% antinuclear antibody in COVID-19 patients, suggesting the existence of autoimmune phenomena in COVID-19 subjects [8].